John Kopchick receiving an honorary doctorate from IUP in 2008
In September, Aarhus University in Denmark presented John Kopchick ’72, M’75 with an honorary doctorate in medicine. One of the world’s top experts on growth hormone and associated growth factors, John has worked in collaboration with Aarhus scientists and students for 20 years. In 1989, he developed the first specific growth hormone antagonist, which became the basis of the drug Somavert, used to treat acromegaly and gigantism. Aarhus researchers assisted with human clinical trials of the drug.
John is a Distinguished Professor of Molecular Biology and Goll-Ohio Eminent Scholar in the Department of Biomedical Sciences at the Heritage College of Osteopathic Medicine and at the Edison Biotechnology Institute at Ohio University.